These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32015090)

  • 41. Baseline serum glucose concentration and symptomatic haemorrhagic transformation in non-diabetic stroke patients treated by intravenous thrombolysis.
    Gnofam M; Leys D; Ponchelle-Dequatre N; Bodenant M; Hénon H; Bordet R; Cordonnier C
    J Neurol; 2013 Nov; 260(11):2786-92. PubMed ID: 23942982
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Blood pressure management and evolution of thrombolysis-associated intracerebral hemorrhage in acute ischemic stroke.
    Mokin M; Kass-Hout T; Kass-Hout O; Zivadinov R; Mehta B
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):852-9. PubMed ID: 21703878
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intravenous thrombolysis for patients with reverse magnetic resonance angiography and diffusion-weighted imaging mismatch: SAMURAI and NCVC rt-PA Registries.
    Sakamoto Y; Koga M; Kimura K; Nagatsuka K; Okuda S; Kario K; Hasegawa Y; Okada Y; Yamagami H; Furui E; Nakagawara J; Shiokawa Y; Okata T; Kobayashi J; Tanaka E; Minematsu K; Toyoda K
    Eur J Neurol; 2014 Mar; 21(3):419-26. PubMed ID: 24261412
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intravenous thrombolysis in stroke mimics: results from the SITS International Stroke Thrombolysis Register.
    Keselman B; Cooray C; Vanhooren G; Bassi P; Consoli D; Nichelli P; Peeters A; Sanak D; Zini A; Wahlgren N; Ahmed N; Mazya MV
    Eur J Neurol; 2019 Aug; 26(8):1091-1097. PubMed ID: 30793434
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early infarct FLAIR hyperintensity is associated with increased hemorrhagic transformation after thrombolysis.
    Kufner A; Galinovic I; Brunecker P; Cheng B; Thomalla G; Gerloff C; Campbell BC; Nolte CH; Endres M; Fiebach JB; Ebinger M
    Eur J Neurol; 2013 Feb; 20(2):281-5. PubMed ID: 22900825
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Extending thrombolysis to 4·5-9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data.
    Campbell BCV; Ma H; Ringleb PA; Parsons MW; Churilov L; Bendszus M; Levi CR; Hsu C; Kleinig TJ; Fatar M; Leys D; Molina C; Wijeratne T; Curtze S; Dewey HM; Barber PA; Butcher KS; De Silva DA; Bladin CF; Yassi N; Pfaff JAR; Sharma G; Bivard A; Desmond PM; Schwab S; Schellinger PD; Yan B; Mitchell PJ; Serena J; Toni D; Thijs V; Hacke W; Davis SM; Donnan GA;
    Lancet; 2019 Jul; 394(10193):139-147. PubMed ID: 31128925
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validation of TURN, a simple predictor of symptomatic intracerebral hemorrhage after IV thrombolysis.
    Asuzu D; Nystrӧm K; Amin H; Schindler J; Wira C; Greer D; Chi NF; Halliday J; Sheth KN
    Clin Neurol Neurosurg; 2016 Jul; 146():71-5. PubMed ID: 27152469
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The safety of intravenous thrombolysis for ischemic stroke in patients with pre-existing cerebral aneurysms: a case series and review of the literature.
    Edwards NJ; Kamel H; Josephson SA
    Stroke; 2012 Feb; 43(2):412-6. PubMed ID: 22156701
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thrombolysis in dementia patients with acute stroke: is it justified?
    Paciaroni M; Pantoni L
    Neurol Sci; 2017 Jan; 38(1):27-31. PubMed ID: 27699498
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does Diffusion Lesion Volume Above 70 mL Preclude Favorable Outcome Despite Post-Thrombolysis Recanalization?
    Tisserand M; Turc G; Charron S; Legrand L; Edjlali M; Seners P; Roca P; Lion S; Naggara O; Mas JL; Méder JF; Baron JC; Oppenheim C
    Stroke; 2016 Apr; 47(4):1005-11. PubMed ID: 26979862
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early epileptic seizures in ischaemic stroke treated by mechanical thrombectomy: influence of rt-PA.
    Ba K; Casolla B; Caparros F; Bricout N; Della Schiava L; Pasi M; Dequatre-Ponchelle N; Bodenant M; Bordet R; Cordonnier C; Hénon H; Leys D
    J Neurol; 2021 Jan; 268(1):305-311. PubMed ID: 32797298
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low Alberta stroke program early computed tomography score within 3 hours of onset predicts subsequent symptomatic intracranial hemorrhage in patients treated with 0.6 mg/kg Alteplase.
    Hirano T; Sasaki M; Tomura N; Ito Y; Kobayashi S;
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):898-902. PubMed ID: 21737309
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of antiplatelet pre-treatment on the risk of intracranial haemorrhage in acute ischaemic stroke after intravenous thrombolysis.
    Dorado L; Millán M; de la Ossa NP; Guerrero C; Gomis M; López-Cancio E; Ricciardi AC; Dávalos A
    Eur J Neurol; 2010 Feb; 17(2):301-6. PubMed ID: 19912320
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Large ischemic lesions on diffusion-weighted imaging done before intravenous tissue plasminogen activator thrombolysis predicts a poor outcome in patients with acute stroke.
    Kimura K; Iguchi Y; Shibazaki K; Terasawa Y; Inoue T; Uemura J; Aoki J
    Stroke; 2008 Aug; 39(8):2388-91. PubMed ID: 18535272
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recent silent infarcts do not increase the risk of haemorrhage after intravenous thrombolysis.
    Stösser S; Ullrich L; Kassubek J; Ludolph AC; Schocke M; Neugebauer H
    Eur J Neurol; 2020 Dec; 27(12):2483-2490. PubMed ID: 32702146
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The relationship of leukoaraiosis, haemorrhagic transformation and prognosis at 3 months after intravenous thrombolysis in elderly patients aged ≥ 60 years with acute cerebral infarction.
    Liu X; Zhang J; Tian C; Wang J
    Neurol Sci; 2020 Nov; 41(11):3195-3200. PubMed ID: 32358704
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Multi-mode MRI-based intravenous thrombolysis with recombinant tissue plasminogen activator (rtPA) reduces hemorrhagic transformation in ischemic stroke patients].
    Lin YH; Lou M; Zhu RY; Yan YQ; Zhen ZC; Ding MP
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 41(6):665-71. PubMed ID: 23239659
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Time-dependence of NIHSS in predicting functional outcome of patients with acute ischemic stroke treated with intravenous thrombolysis.
    Wu Z; Zeng M; Li C; Qiu H; Feng H; Xu X; Zhang H; Wu J
    Postgrad Med J; 2019 Apr; 95(1122):181-186. PubMed ID: 30975729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.